Back
AbbVie Vs. Eli Lilly and Industry Stock Comparison
Buy
64
ABBV
AbbVie
Last Price:
165.40
Seasonality Move:
-0.2%
Buy
64
LLY
Eli Lilly and
Last Price:
783.50
Seasonality Move:
1.62%
Buy
64
AbbVie (ABBV)
is a Buy
Is AbbVie a Buy, Sell or Hold?
- The current AbbVie [ABBV] share price is $166.42. The Score for ABBV is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- ABBV is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
64
Eli Lilly and (LLY)
is a Buy
Is Eli Lilly and a Buy, Sell or Hold?
- The current Eli Lilly and [LLY] share price is $770.00. The Score for LLY is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- LLY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ABBV Stock Price Chart
LLY Stock Price Chart
What is Eli Lilly and's stock price today?
-
The Eli Lilly and share price today is $770.00
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LLY is experiencing slight selling pressure.
ABBV Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.43 | Sell |
Relative Strength Index (14 RSI): | 54.3 | Buy |
Chaikin Money Flow: | 4605251 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (160.78 - 166.14) | Buy |
Bollinger Bands (100): | (161.66 - 177.02) | Sell |
LLY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.96 | Buy |
Relative Strength Index (14 RSI): | 53.03 | Buy |
Chaikin Money Flow: | -418938 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (736.7 - 773.3) | Buy |
Bollinger Bands (100): | (659.62 - 785.64) | Buy |
ABBV Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 162.38 | Buy |
20-day SMA: | 163.35 | Buy |
50-day SMA: | 169.82 | Sell |
200-day SMA: | 158.3 | Buy |
8-day EMA: | 163.44 | Buy |
20-day EMA: | 163.92 | Buy |
50-day EMA: | 166.79 | Sell |
200-day EMA: | 160.95 | Buy |
LLY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 769.55 | Buy |
20-day SMA: | 757.72 | Buy |
50-day SMA: | 760.26 | Buy |
200-day SMA: | 646 | Buy |
8-day EMA: | 769 | Buy |
20-day EMA: | 763.13 | Buy |
50-day EMA: | 752.61 | Buy |
200-day EMA: | 651.12 | Buy |
AbbVie Earnings Growth & ABBV Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, an increase next quarter of $0.20 per share, an increase this year of $0.10 per share, and an increase next year of $0.83 per share.
Eli Lilly and Earnings Growth & LLY Earnings Dates
- Analysts estimate an earnings increase this quarter of $3.91 per share, an increase next quarter of $0.07 per share, an increase this year of $7.48 per share, and an increase next year of $5.24 per share.
AbbVie Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Eli Lilly and Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |